Sickle Cell Anemia Drug Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC571

Introduction

Sickle cell disease is an inherited group of syndrome in which RBCs twist to sickle shape. A cluster of syndromes causes red blood cells (RBCs) to become distorted and break down. Some of the common symptoms of sickle cell disease are pain, infection and fatigue. Popular treatments for this disease include rarely a bone-marrow transplant, blood transfusions and medication.

Market Dynamics

Growing geriatric population in major economies and rising healthcare spending and demand for drug therapy in combination with blood transfusion and surgeries are driving the market growth. In addition, overall cost of sickle cell disease diagnosis is reduced, which in turn, is majorly influencing the market growth. However, adverse effects from sickle cell anemia such as intravenous catheter associated infections, liver in-toxicity and low hemoglobin are impeding the growth of this market. Government emphasis on spreading awareness about sickle cell anemia cure combined with augmentation of FDA approved drug accessibility are propelling the market expansion over the forecast period.

 Market Classification

The sickle cell anemia drug market is segmented on the basis of mode of delivery, end-user and geography. Based on mode of delivery, the market is classified into oral and injection. Based on type, the market is classified into hospital, clinic and others. Based on geography, market is divided into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Report Coverage

Market

Sickle Cell Anemia Drug Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Mode of Delivery, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

The market players in the sickle cell anemia drug market include Alnylam Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Emmaus Life Sciences, Inc., Novartis AG, AstraZeneca Plc., Sangamo Therapeutics, Inc., bluebird bio, Inc., Global Blood Therapeutics Inc., Bristol-Myers Squibb Company, Acceleron Pharma, Inc. and Arena Pharmaceuticals, Inc. among others.

Market Segmentation

Market By Mode of Delivery

·         Oral

·         Injection

Market By End-Users

·         Hospital

·         Clinic

·         Others

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction The report provides analysis of global Cardiovascular & Soft Tissue Repair Patches market for the period 2016-2026, wherein 2019 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Cardiovascular & Soft Tissue Repair Patches market is expected to grow at noteworthy CAGR around 8 % throughout the forecas

Virus Filtration Market (By Product Type: Virus Filters & Filtration Systems, Kits & Reagents, Services; By Application: Biological [Blood & Blood Products, Tissue & Tissue Products, Vaccines & Therapeutics, Cellular & Gene Therapy Products, Stem Cell Products], Medical Devices, Water Purification, Air Purification; By End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organization, Medical Devices Companies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Virus filtration are mainly used to maintain a pathogen such as bacteria, virus, and microbe’s free environment. Presence of pathogens in labs, and biotechnology industries lead to the contamination of water, air, and biotheraputics. Virus filtration maintains the environment and products safety. It also ensures that the products manufactured are of high grade. The market research study on “Virus Filtration Market

Alopecia Market (By Disease Type: Alopecia Areata, Androgenetic Alopecia; By End Users: Homecare Settings, Dermatology Clinics; By Distribution Channel: Prescriptions, OTC) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Alopecia refers to loss of hair from parts of the head or body. Sedentary lifestyle, and unhealthy diets is leading loss of hair among masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. Overall rise in geriatric population and rising awareness and preference for surgical hair transplants and other such treatments is also a positive influence for the global market in the forecast period.

Parenteral Nutrition Market (By Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction: The global parenteral nutrition market size estimated at nearly USD 8.36 billion by 2026. The global parenteral nutrition market is likely to expand at a CAGR of more than 5.9% from 2018 to 2026. Market Dynamics Presence of a large number of malnourished childre

Medical Billing Outsourcing Market (By Component: In-House, Outsourced; By Service: Back-End, Middle-End, Front-End; By End-Use: Physician Clinics, Hospitals, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The method of outsourcing the billing strategy for medicinal treatment is known as billing. Medical billing outsourcing helps medicinal houses and emergency clinics to concentrate just on therapeutic treatment and administrations. These aides in streamlining the intricate accumulation procedure to defeat nonstop decreases in repayments to fulfill HIPPA act. The report

Cart Summary